IRISDOREME.NS(IRISDOREME.NS)
IRISDOREME.NS
No analyst ratings available
No analyst price targets available for IRISDOREME.NS
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.38B | $2.95B | $3.64B |
| Low | $2.38B | $2.95B | $3.64B |
| High | $2.38B | $2.95B | $3.64B |
| EBITDA Avg | $442M | $550M | $677M |
| Low | $442M | $550M | $677M |
| High | $442M | $550M | $677M |
| EBIT Avg | $340M | $423M | $521M |
| Low | $340M | $423M | $521M |
| High | $340M | $423M | $521M |
| Net Income Avg | $269M | $337M | $425M |
| Low | $269M | $337M | $425M |
| High | $269M | $337M | $425M |
| EPS Avg | $1.41 | $1.77 | $2.23 |
| Low | $1.41 | $1.77 | $2.23 |
| High | $1.41 | $1.77 | $2.23 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $260M | $400M | $310M | $460M | $320M | $450M |
| Low | $260M | $400M | $310M | $460M | $320M | $450M |
| High | $260M | $400M | $310M | $460M | $320M | $450M |
| EBITDA Avg | $48M | $74M | $58M | $86M | $60M | $84M |
| Low | $48M | $74M | $58M | $86M | $60M | $84M |
| High | $48M | $74M | $58M | $86M | $60M | $84M |
| EBIT Avg | $37M | $57M | $44M | $66M | $46M | $64M |
| Low | $37M | $57M | $44M | $66M | $46M | $64M |
| High | $37M | $57M | $44M | $66M | $46M | $64M |
| Net Income Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |